Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · Real-Time Price · USD

0.8017

-0.0293 (-3.53%)

At close: Aug 20, 2026, 4:00 PM EDT

0.7813

-0.0204 (-2.54%)

After-hours: Aug 20, 2026, 6:15 PM EDT

Oncolytics Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4.12	5.2	11.08	26.44	8.62	32.61
Short-Term Investments	-	-	-	-	15.13	-
Cash & Short-Term Investments	4.12	5.2	11.08	26.44	23.75	32.61
Cash Growth	-61.63%	-53.05%	-58.09%	11.33%	-27.17%	33.08%
Other Receivables	1.21	0.57	0.05	0.01	0.02	0.07
Receivables	1.21	0.57	0.05	0.01	0.02	0.07
Prepaid Expenses	1.74	1.07	1.31	2.46	1.25	2.19
Other Current Assets	-	-	-	-	1.34	0.62
Total Current Assets	7.07	6.84	12.44	28.91	26.37	35.48
Property, Plant & Equipment	0.6	0.74	0.99	0.49	0.48	0.77
Other Long-Term Assets	-	-	-	-	0.74	-
Total Assets	7.67	7.58	13.42	29.4	27.58	36.25

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.41	3.5	0.76	0.82	1.66	0.47
Accrued Expenses	1.68	2.33	2.57	1.89	1.03	1.1
Current Portion of Leases	0.14	0.19	0.2	0.1	0.16	0.23
Other Current Liabilities	-	0.08	1.36	0.4	0.06	0.32
Total Current Liabilities	5.23	6.1	4.89	3.21	2.91	2.13
Long-Term Leases	0.31	0.37	0.56	0.22	0.12	0.29
Long-Term Unearned Revenue	4.91	4.91	4.68	5.1	4.97	5.32
Other Long-Term Liabilities	3.39	-	-	-	-	-
Total Liabilities	13.84	11.38	10.12	8.52	8	7.73

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	-	-	-	326.29	298.53	309.25
Additional Paid-In Capital	435.79	419.47	397.67	31.89	29.59	26.99
Retained Earnings	-448.18	-429.5	-400.74	-337.72	-309.03	-310.88
Comprehensive Income & Other	6.23	6.23	6.36	0.41	0.49	3.17
Shareholders' Equity	-6.17	-3.8	3.3	20.87	19.58	28.53
Total Liabilities & Equity	7.67	7.58	13.42	29.4	27.58	36.25

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.45	0.56	0.76	0.32	0.28	0.52
Net Cash (Debt)	3.67	4.64	10.32	26.12	23.47	32.09
Net Cash Growth	-63.59%	-55.04%	-60.49%	11.27%	-26.86%	32.67%
Net Cash Per Share	0.03	0.05	0.13	0.39	0.40	0.60
Filing Date Shares Outstanding	127.51	116.13	86.42	75.42	62.83	57.11
Total Common Shares Outstanding	124.64	108.02	80.02	74.42	61.33	55.04
Working Capital	1.84	0.74	7.55	25.7	23.45	33.36
Book Value Per Share	-0.05	-0.04	0.04	0.28	0.32	0.52
Tangible Book Value	-6.17	-3.8	3.3	20.87	19.58	28.53
Tangible Book Value Per Share	-0.05	-0.04	0.04	0.28	0.32	0.52
Machinery	-	0.62	0.6	0.56	0.55	0.54
Leasehold Improvements	-	0.13	0.13	0.17	0.17	0.18

SEC Filings: 10-K · 10-Q